Meditation as a Tool for Symptom Relief in Schizophrenia: Bridging Neuroscience and Mental Health
Meditation as an adjunctive therapy for schizophrenia reduces symptom severity and improves quality of life. Quantitative analysis of clinical trials showed consistent reductions in PANSS scores and improved quality-of-life measures. Qualitative interviews with patients and practitioners revealed increased self-awareness and reduced distress from hallucinations. Providers emphasized the need for personalized meditation protocols. The findings suggest meditation modulates neural circuits involved in stress and emotional dysregulation, offering a promising complementary strategy that requires interdisciplinary collaboration and cultural sensitivity.